Oncomatryx will be present at the Congress of the European Society of Medical Oncology in Munich
ESMO 2018 Congress
Munich, Germany – 19 Oct – 23 Oct 2018
Dr. Myriam Fabre (Oncomatryx R&D Director) presents the poster:
OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments
Myriam Fabre1,6, Cristina Ferrer1, Saioa Domínguez-Hormaetxe1, Roland Kontermann2, Klaus Pfizenmaier2, Oliver Seifert2, Pedro P. López-Casas3, Muhammad Abbas4, Wolfgang Richter4, Laureano Simon1, Manuel Hidalgo5.